Get the Stockscreener App
2.71
5.90%
-0.17
Pre-market:
2.75
0.04
+1.48%
Stereotaxis Inc stock is traded at $2.71, with a volume of 531.95K.
It is down -5.90% in the last 24 hours and up +22.07% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$2.88
Open:
$2.84
24h Volume:
531.95K
Relative Volume:
1.12
Market Cap:
$245.67M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-10.04
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
-2.52%
1M Performance:
+22.07%
6M Performance:
+31.55%
1Y Performance:
+18.34%
1-Day Range:
$2.6703
$2.86
1-Week Range:
$2.6703
$2.92
52-Week Range:
$1.54
$3.051
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.71 | 261.08M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
469.07 | 169.67B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
188.15 | 55.31B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
270.99 | 40.19B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.27 | 39.46B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
243.74 | 17.76B | 2.96B | 487.70M | 344.00M | 6.68 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Why Stereotaxis Inc. is moving todayTrade Risk Report & Fast Entry High Yield Stock Tips - Newser
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter - GlobeNewswire
What recovery options are there for Stereotaxis Inc.Buy Signal & Expert Approved Trade Ideas - Newser
Smart tools for monitoring Stereotaxis Inc.’s price action2025 Key Lessons & Technical Pattern Based Signals - Newser
Backtesting results for Stereotaxis Inc. trading strategies2025 Analyst Calls & Low Risk High Reward Ideas - Newser
World's First Robotic HD Cardiac Mapping: Stereotaxis MAGiC Sweep Makes US Commercial Debut - Stock Titan
Stereotaxis to Present at Upcoming Investor Conferences - GlobeNewswire
Surgical Robotics Leader Stereotaxis to Showcase Growth Strategy at Major Investment Conferences in NYC - Stock Titan
Real time social sentiment graph for Stereotaxis Inc.Market Performance Report & AI Powered Market Entry Strategies - Newser
What are Stereotaxis Inc.’s recent SEC filings showingWeekly Investment Report & Stock Market Timing Techniques - خودرو بانک
What MACD and RSI say about Stereotaxis Inc.July 2025 EndofMonth & Reliable Price Action Trade Plans - Newser
Is Stereotaxis Inc. part of any major indexJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - خودرو بانک
Technical analysis overview for Stereotaxis Inc. stock2025 Big Picture & Growth Oriented Trade Recommendations - Newser
Is Stereotaxis Inc. affected by consumer sentiment2025 Macro Impact & Weekly Return Optimization Alerts - خودرو بانک
Is Stereotaxis Inc. benefiting from innovation trendsWeekly Gains Report & Short-Term Trading Opportunity Alerts - خودرو بانک
Stereotaxis Inc. Price Targets Raised After Rebound getLinesFromResByArray error: size == 0 - kangso.co.kr
Price Consolidation Hints at Upcoming Move in Stereotaxis Inc.July 2025 Earnings & Real-Time Buy Zone Alerts - beatles.ru
How to forecast Stereotaxis Inc. trends using time seriesJuly 2025 Intraday Action & Daily Volume Surge Signals - Newser
Exit strategy if you’re trapped in Stereotaxis Inc.2025 Momentum Check & Fast Moving Stock Watchlists - Newser
Chart overlay techniques for tracking Stereotaxis Inc.Weekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Market reaction to Stereotaxis Inc.’s recent news2025 Retail Activity & Real-Time Price Movement Reports - Newser
How to build a custom watchlist for Stereotaxis Inc.Rate Hike & Scalable Portfolio Growth Ideas - Newser
Sector Rotation Brings Stereotaxis Inc. Into Focus getLinesFromResByArray error: size == 0 - thegnnews.com
What’s the recovery path for long term holders of Stereotaxis Inc.Quarterly Market Review & Accurate Buy Signal Notifications - Newser
Published on: 2025-08-30 03:26:25 - Newser
Stereotaxis Enters $50M Sales Agreement with Roth Capital - TipRanks
What MACD signals say about Stereotaxis Inc.Portfolio Update Report & Verified Technical Trade Signals - Newser
Real time breakdown of Stereotaxis Inc. stock performanceJuly 2025 Closing Moves & Reliable Breakout Forecasts - Newser
Sentiment analysis tools applied to Stereotaxis Inc.July 2025 Price Swings & Verified Trade Idea Suggestions - Newser
Will Stereotaxis Inc. outperform the marketJuly 2025 Market Mood & Low Drawdown Investment Strategies - Newser
Stereotaxis’ Strategic Capital Raises and Path to Sustainable Growth - AInvest
Stereotaxis enters sales agreement of $50 million common stock with Roth Capital - MarketScreener
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):